Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy

Clinical trial NCT06770257 · WITHDRAWN

Trial details

NCT number: NCT06770257
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2025-12-10
Primary completion: 2026-12-10
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.